Sivik Global Healthcare’s Envista NVST Stock Holding History

Sivik Global Healthcare’s Portfolio NVST Stock Details NVST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-60,000	Closed	-$2.92M	–	51
2022 Q1	$2.92M	Buy	+60,000	New	+$2.77M	1.21%	39

Other funds holding NVST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sivik Global Healthcare's NVST Position: Q2 2022 in Review

Sivik Global Healthcare sold out of Envista (NVST) in Q2 2022, closing a stake of 60,000 shares — an estimated $2.92M sold.

Sivik Global Healthcare first reported a position in NVST in Q1 2022 and held it in 1 quarter. The position peaked at $2.92M in Q1 2022. 339 funds tracked by Wall St. Rank hold NVST as of Q2 2022.

Sivik Global Healthcare reported no remaining Envista position as of Q2 2022 after selling out during the quarter.
Sivik Global Healthcare sold 60,000 Envista shares in Q2 2022, an estimated $2.92M.
Sivik Global Healthcare first reported a position in Envista in Q1 2022 and held it in 1 quarter.
Sivik Global Healthcare's Envista position peaked at $2.92M in Q1 2022.
339 funds tracked by Wall St. Rank held Envista as of Q2 2022.

Based on Sivik Global Healthcare's 13F filing for Q2 2022, filed 10 Aug 2022.